Weight-Loss Drug Ozempic May Worsen Eating Disorders, Experts Warn
New York, NY – Over the past few years, the rise of the weight loss drug Ozempic has caught the attention of many individuals looking to shed significant pounds. Originally approved by the Food and Drug Administration (FDA) in 2017 for the treatment of type 2 diabetes, Ozempic is a glucagon-like peptide 1 (GLP-1) drug that has shown potential in aiding weight loss in addition to improving blood sugar levels when combined with diet and …